Clinical Trials Browser

Phase 1/2 × Glioblastoma × pexidartinib × Clear all

NCT01790503 2020-06-30

A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma

Phase 1/2 Completed

65 enrolled 26 charts

Glioblastoma